Primary graft failure after heart transplantation: Urgent need for a consensus guideline

Transplantation

Volumn 91, Issue 6, 2011, Pages

  Beiras Fernandez, Andres ^a   Kaczmarek, Ingo ^a   Weis, Florian ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; INOTROPIC AGENT; LEVOSIMENDAN; MILRINONE;

CONSENSUS; DEATH; DRUG MEGADOSE; GRAFT FAILURE; HEART EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; INCIDENCE; LETTER; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETRANSPLANTATION; STATISTICAL ANALYSIS;

HEART TRANSPLANTATION; HUMANS; PRACTICE GUIDELINES AS TOPIC; TREATMENT FAILURE;

EID: 79952760911     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182094a83     Document Type: Letter

References (3)

1. Russo MJ, Iribarne A, Hong KN, et al. Factors associated with primary graft failure after heart transplantation. Transplantation 2010; 90: 444.
2. Lima B, Rajagopal K, Petersen RP, et al. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. Circulation 2006; 114(1 suppl): I27.
3. Weis F, Beiras-Fernandez A, Kaczmarek I, et al. Levosimendan: A new therapeutic option in the treatment of primary graft dysfunction after heart transplantation. J Heart Lung Transplant 2009; 28: 501.